Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis

Full text
Show less -
Tognon, Raquel [1] ; Gasparotto, Elainy P. L. [1] ; Neves, Renata P. [1] ; Nunes, Natalia S. [1] ; Ferreira, Aline F. [1] ; Palma, Patricia V. B. [2] ; Kashima, Simone [2] ; Covas, Dimas T. [2, 3] ; Santana, Mary [4] ; Souto, Elizabeth X. [4] ; Zanichelli, Maria Aparecida [5] ; Simoes, Belinda P. [3] ; de Souza, Ana Maria [1] ; Castro, Fabiola A. [1]
Total Authors: 14
[1] Univ Sao Paulo, Dept Clin Toxicol & Bromatol Anal, Ribeirao Preto Sch Pharmaceut Sci, BR-14049 Ribeirao Preto - Brazil
[2] Univ Sao Paulo, Reg Blood Ctr Ribeirao Preto, Ribeirao Preto Sch Med, Clin Hosp, BR-14049 Ribeirao Preto - Brazil
[3] Univ Sao Paulo, Dept Clin Med, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto - Brazil
[4] Brigadeiro Hosp Sao Paulo, Sao Paulo - Brazil
[5] Inst Canc Treatment Children ITACI, Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: Journal of Hematology & Oncology; v. 5, FEB 2 2012.
Web of Science Citations: 14

Background: Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF) are Chronic Myeloproliferative Neoplasms (MPN) characterized by clonal myeloproliferation/myeloaccumulation without cell maturation impairment. The JAK2 V617F mutation and PRV1 gene overexpression may contribute to MPN physiopathology. We hypothesized that deregulation of the apoptotic machinery may also play a role in the pathogenesis of ET and PMF. In this study we evaluated the apoptosis-related gene and protein expression of BCL2 family members in bone marrow CD34(+) hematopoietic stem cells (HSC) and peripheral blood leukocytes from ET and PMF patients. We also tested whether the gene expression results were correlated with JAK2 V617F allele burden percentage, PRV1 overexpression, and clinical and laboratory parameters. Results: By real time PCR assay, we observed that A1, MCL1, BIK and BID, as well as A1, BCLW and BAK gene expression were increased in ET and PMF CD34(+) cells respectively, while pro-apoptotic BAX and anti-apoptotic BCL2 mRNA levels were found to be lower in ET and PMF CD34(+) cells respectively, in relation to controls. In patients' leukocytes, we detected an upregulation of anti-apoptotic genes A1, BCL2, BCL-XL and BCLW. In contrast, pro-apoptotic BID and BIMEL expression were downregulated in ET leukocytes. Increased BCL-XL protein expression in PMF leukocytes and decreased BID protein expression in ET leukocytes were observed by Western Blot. In ET leukocytes, we found a correlation between JAK2 V617F allele burden and BAX, BIK and BAD gene expression and between A1, BAX and BIK and PRV1 gene expression. A negative correlation between PRV1 gene expression and platelet count was observed, as well as a positive correlation between PRV1 gene expression and splenomegaly. Conclusions: Our results suggest the participation of intrinsic apoptosis pathway in the MPN physiopathology. In addition, PRV1 and JAK2 V617F allele burden were linked to deregulation of the apoptotic machinery. (AU)

FAPESP's process: 10/01756-3 - MicroRNAs expression on CD34+ cells and leukocytes in Polycythemia Vera
Grantee:Natália de Souza Nunes
Support type: Scholarships in Brazil - Master